Analyst consensus rating
Eledon Pharmaceuticals Analyst Rating: Strong Buy
ELDN is rated Strong Buy by 5 analysts with a $9.00 target. As of 2026-08-21.
Direct answer
Eledon Pharmaceuticals's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.00.
Forecast evidence checked August 21, 2026.
Get free Eledon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.52
- Average price target
- $9.00
- High price target
- $12.00
- Low price target
- $7.00
- Low target gap
- +98.9%
- Target upside
- +155.7%
- High target gap
- +240.9%
- Target range width
- 142%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Eledon Pharmaceuticals?
Eledon Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $9.00.
How far are Eledon Pharmaceuticals's low and high targets from the recorded price?
The low target implies +98.9%, while the high target implies +240.9%.
How many analysts are included in Eledon Pharmaceuticals's consensus?
The verified consensus includes 5 analysts.
How is Eledon Pharmaceuticals's target upside or downside calculated?
The average target of $9.00 is divided by the recorded price of $3.52, then one is subtracted to produce +155.7%. This does not guarantee a future return.
When was Eledon Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.